expert clinical analysis. practice advice. policy

UrologyTimes.comLast revised: 05/15/2019

Expert clinical analysis. Practice advice. Policy perspectives.

2019 media kit


ModernMedicine Network includes over 30 brands, spanning 17 markets to meet the marketing needs of the healthcare field.

ModernMedicine Network reaches all sectors of the healthcare field with tactical brands thru multiple touchpoints. We take pride in our creative approach to targeting qualified audiences, understanding those audiences and delivering relevant, practical content to decision makers. From custom solutions to standard display, our team optimizes the diversity and reach of the ModernMedicine Network to meet your expectations.

Engaging healthcare professionals with content that matters.

For more information on ModernMedicine brands and marketing materials go to ModernMedicine.com

1.25M+ database of HCPs

1.5M unique

visitors/month

3.5M average page views/month

780K print

subscribers

1000+ KOL’s on

Editorial boards



2019 media kit

12K+ Qualified Print

Circulation

6.5 Mins. Time

on Site*

21.9K Unique visitors*

65K+ Page views/

month*

2.1 Pages

per visit*

Urology Times is the go-to source for clinical analysis, policy perspectives, practical advice and online resources for urologists and allied health professionals.

www.urologytimes.com

Inside

Source: Urol Pract 2017; 4:171

For the full article, please turn to page 14

Lisette Hilton / UT Correspondent

NPs and PAs take on expanding role that often includes performing procedures

FOCAL THERAPY

John W. Davis, MD

September 2018 VOL. 46, NO. 9 UrologyTimes.comSeptember 2018 VOL. 46, NO. 9 UrologyTimes.com

with Readers*

Since 2001*Source: Kantar Media


Bladder instillation

Intracavernosal injections for ED

Urodynamics interpretation

Percutaneous tibial nerve stimulation

Chemotherapy injections

LHRH antagonist administration

Urodynamics (place catheters/perform

test)

Cystoscopy for stent removal

Neuromodulation with InterStim pro-

gramming

Priapism injection treatment

55%

40.6%

38.8%

33.8%

29.4%

27.5%

25%

23.8%

23.1%

2014

Source: Data from 2017 AUA Annual Census/APP Module compiled by Raymond Fang et al

[ PROSTATE HEALTH MONTH ] BPH 3, 4, 5, 6 | PROSTATE CANCER 7, 10, 14, 33

>70%of urologists worked with one or

more APPs in 2017, vs. 62.7% in 2015

Source: 2015 and 2017 AUA Annual Census data

SIMPLE OFFICE PROCEDURES

BILLED BY APPs

PROCEDURES APPs PERFORM INDEPENDENTLY

230,683

54,549

2003

56.3%

Q&A 4 CLINICAL UPDATES

Which BPH procedures best reduce need for medication?

10 FROM DR. MIAN

5-ARI use reduces prostate Ca risk for up to 16 years

11 HANDS ON

Opportunistic salpingectomy in female urologic surgery

APPs: Urology’s new normal

Focal therapy for prostate Ca: Ready for prime time?In this interview, John W. Davis, MD,

of the University of Texas MD Anderson

Cancer Center, Houston, discusses

the advantages and limitations of focal

therapy for low-risk prostate cancer, the

ideal candidate, and what current guide-

lines say about its use.

Please see APPS, on page 29

For U.S. urologists, working with nurse practitioners and physician assistants has become more the norm than the exception.

More than 70% of practicing urologists work with one or more nurse practitioners and physi-cian assistants, collectively called advanced prac-tice providers (APPs), according to 2017 AUA Census data. By comparison, 62.7% of urologists worked with an APP in 2015.

“A decade ago it was rare to have advanced practice providers as part of routine urologic care. Now they’re integral and a necessary part of any active urologic practice,” said Bradley A. Erickson, MD, MS, associate professor of urol-ogy and surgery, University of Iowa, Iowa City.

Urology isn’t the only specialty with a growing

Inside

with Readers*


Si 2001Since 2001*Source: Kantar Media


Urologists negotiating employ-ment, payer, or other contracts often feel like they’re navigating unknown, hazardous terrain.

Thomas Stringer, MD, associate professor and associate chairman of urology at Uni-versity of Florida, Gainesville, often reviews residents’ employment contracts. He recalls a recent hospital contract, where he urged the resident to seek clarification in key areas. But the resident wanted the job so much, he felt uncomfortable asking questions and poten-tially turning off the employer.

That’s a mistake, according to Dr. Stringer.“This [contract] is your conditions of

employment. You really need to define what those are so you can feel satisfied once you sign the thing. I think physicians tend to be pretty

anxious about nego-tiating on their own behalf,” he said.

Dr. Stringer, who for 7 years directed the course, “Physician Contract Negotiation: Employment and Owner-ship in the Current Economic Cli-mate,” at AUA annual meetings, says urologists are increasingly called upon to negotiate important and binding documents, like employment contracts.

“More and more physicians, in gener-al, are employed. In the year 2000, almost 60% of all physicians were shareholders in their practices. Currently, that’s clos-er to 30% of all physicians,” Dr. Stringer said. “Our data suggests that the number

PCNL tips and tricks: Access is everything

Win-win contractnegotiations



Q&A

COLLABORATE

Contract negotiations are about col-laborating, not competing. In fact, the process should involve conversation, not negotiation.

KNOW WHO THE PARTIES ARE

Are you contracting on your own behalf or that of the entire practice? This is especially important in managed care contracts.

LOOK FOR WIN-WINS

Explore factors that can be positive for you but also for the practice or other entity you’re negotiating with.

PREPARE

Do your homework. Plenty of information is available online, including from the MGMA (www.mgma.com) and AAMC (www.aamc.org/).

KNOW WHAT YOU WANT

Understand what your top concerns and priorities are, especially since you will likely be unable to negotiate everything you want.

August 2018 VOL. 46, NO. 8 UrologyTimes.com

KEYS TO

SUCCESSFUL

NEGOTIATION

Please see NEGOTIATION, on page 42

STONE SURGERY

Thomas Chi, MD

Practical strategies are available to help you collaborate, not compete

24 MEN’S HEALTH

Alcohol and the prostate gland: Friend or foe?

26 CODING

Medicare proposed rule outlines signifi cant changes

50 MALPRACTICE

Wrong antibiotic leadsto $250K lawsuit

In this interview, Thomas Chi, MD, of the

University of California, San Francisco dis-

cusses how he performs PCNL, explains why

he uses ultrasound instead of fluoroscopy,

and offers advice to urologists looking to

gain more experience with the procedure.

*based on 6 month rolling average

6.4K US E-Newssubscribers


print solutions

Trimming Live matter: 7-1/2” x 6-1/4”Trim size: 8-1/2” x 7-1/4”Bleed size: 8-3/4” x 7-1/2”Thickness: Up to four pages; maximum 100# Text to minimum 70# text paperCover tips jog to the bottom.Keep live matter 3/4” from edges & gutter trim.

If client supplies, please provide as trim size, 80# stock weight.

TrimmingSize: Should not be smaller than ¾” and larger than the host publication (9”x12”).

Weight: Max 3.3 Oz

Thickness: Cannot exceed 1/4”.

Finishing: Outsert should have closed edges (folded or tabbed) to polybag the outsert.

Other: Outserts must be flexible. Pieces must bend without damage while applying moderate pressure at least 1 inch vertically when lying flat over an edge half the distance of piece. Please send samples for test run so as to avoid/manage any issues in the press/bindery or with shipping.

COVER TIPS

OUTSERTS

Grab the reader’s attention with an exclusive Cover Tip, an effective way to enhance brand awareness, communicate timely information, or to lead the reader to additional content within the publication. Make a statement and be front of mind with your target audience. Only one cover tip per issue is available, contact your sales representative to take advantage of this powerful opportunity.

Outserts are poly-bagged with the publication and allow the sponsor to tell a rich story and engage the reader with a journey. This high visibility position can accommodate many sizes and opportunities. Contact your sales representative to explore the options.

Be seen first. Limited availability for this high impact position.

Consult publisher for availability and pricing.Consult publisher for availability and pricing.

Consult publisher for availability and pricing.

Inside





FOCAL THERAPY

John W. Davis, MD

September 2018 VOL. 46, NO. 9 UrologyTimes.comSeptember 2018 VOL. 46, NO. 9 UrologyTimes.com

with Readers*




Intracavernosal injections for ED

Urodynamics interpretation

Percutaneous tibial nerve stimulation

Chemotherapy injections

LHRH antagonist administration

Urodynamics (place catheters/perform

test)

Cystoscopy for stent removal

Neuromodulation with InterStim pro-

gramming

Priapism injection treatment

55%

40.6%

38.8%

33.8%

29.4%

27.5%

25%

23.8%

23.1%

2014




more APPs in 2017, vs. 62.7% in 2015



BILLED BY APPs


230,683

54,549

2003

56.3%


Which BPH procedures best reduce need for medication?

10 FROM DR. MIAN

5-ARI use reduces prostate Ca risk for up to 16 years

11 HANDS ON

Opportunistic salpingectomy in female urologic surgery


Focal therapy for prostate Ca: Ready for prime time?In this interview, John W. Davis, MD,








For U.S. urologists, working with nurse practitioners and physician assistants has become more the norm than the exception.

More than 70% of practicing urologists work with one or more nurse practitioners and physi-cian assistants, collectively called advanced prac-tice providers (APPs), according to 2017 AUA Census data. By comparison, 62.7% of urologists worked with an APP in 2015.

“A decade ago it was rare to have advanced practice providers as part of routine urologic care. Now they’re integral and a necessary part of any active urologic practice,” said Bradley A. Erickson, MD, MS, associate professor of urol-ogy and surgery, University of Iowa, Iowa City.


Your Custom Message Here


print solutions

Paper Stock: Text Pages: 45# coated.

Covers: 100# coated.

Type of Binding: Saddlestitch. Jogs to head.

Additional SpecificationsLive matter: Hold 3/8” from trim on all sides.

Trim size of journal: 10.5” X 13.75”

Ad Size (inches) Trim Sizes (Width x Depth)

Bleed Sizes (Width x Depth)

Live area (Width x Depth)

Tab Spread 21 x 13.75 21.25 x 14 20.25 x 13

Tab Page 10.5 x 13.75 10.75x14 9.75 x 13

1/2 Tab Horizontal 10.5 x 6.75 10.75 x 7 9.75 x 6

1/2 Tab Vertical 5.0417 x 13.75 5.2917 x 14 4.2917 x 13

1/2 Tab Spread Horiz 21 x 6.75 21.25 x 7 20.25 x 6

Island 6.57 x 10.06 6.82 x 10.32 5.8 x 9.7

Island Spread 13.12 x 10.06 13.37 x 10.32 13.08 x 9.7

1/3 Vertical block 4.36 x 10.06 4.61 x 10.32 3.6 x 9.7

1/3 Vertical 3.5 x 13.75 3.75 x 14 2.75 x 13

1/4 Vertical Block 5.0417 x 6.75 5.2917 x 7 4.2917 x 6

1/4 Horizontal 10.5 x 3.25 10.75 x 3.50 9.75 x 2.50

1/4 Horizontal Block 6.57 x 5.125 6.82 x 5.375 5.8 x 4.75

AD SIZES (IN INCHES)

Trim: 3.5 x 13.75

Bleed: 3.75 x 14

1/3 Vertical

Trim: 10.5 x 13.75Bleed: 10.75 x 14

Tab Page

Trim: 21 x 13.75Bleed: 21.25 x14

Tab Spread

Trim: 6.57 x 10.06

Bleed: 6.82 x 10.32

Island

1/3 Vertical block

Trim: 4.36 x 10.06

Bleed: 4.61 x 10.32

Trim: 10.5 x 6.75

Bleed: 10.75 x 7

1/2 Tab Horizontal 1/2 Tab Vertical

Trim: 5.0417 x 13.75

Bleed: 5.2917 x 14

1/2 Tab Spread Horiz

Trim: 21 x 6.75Bleed: 21.25 x 7

Island Spread

Trim: 13.12 x 10.06

Bleed: 13.37 x 10.32

Trim: 5.0417 x 6.75

Bleed: 5.2917 x 7

1/4 Vertical Block

Trim: 10.5 x 3.25

Bleed: 10.75 x 3.50

1/4 Horizontal

Trim: 6.57 x 5.125

Bleed: 6.82 x 5.375

1/4 Horizontal Block


PRINT DISPLAY ADVERTISING RATES – FULL-RUN:

Color: In addition to earned B&W Rates. Charge per color/page or fraction

Second Color (magenta, cyan, yellow): .......................................................................................................................1,394 Matched color (all PMS excluding 800 series): ............................................................................................................ 1,718 Sheen/Metallic/Fluorescent color (PMS 800 series): .................................................................................................. 3,236 3- and 4-color process: ............................................................................................................................................ 3,236 5-color: .....................................................................................................................................................................6,447 Insert Tip-in fee: ........................................................................................................................ $585 non-commissionable

Covers and Premium Positions (non-cancelable)*:Add the premium for positions to the earned B&W rate. Then add charge for color.

Cover Rates: Second cover: 25% premium | Third cover: 15% premium Fourth cover: | 50% premium

Premium Positions: Preferred Position: 10% premium Must be a minimum of one full page of color.

Special Position Charge: A 10% per page special position charge is incurred when requesting consecutive right-hand pages or other special positioning.

* Does not include 4C process charges. When a cover is included in a multiple-page space unit, all pages must be full pages.

Cover Tips/Outserts:Consult publisher for rates and availability.

Cancellation Policy with Letter of Agreement:

• 60 days or more prior to issue ad close deadline, no charge.

• 30–60 days prior to issue ad close deadline, 50% of contract rate.

• 30 days or less prior to issue ad close deadline, 100% of contract rate.

Demographic Rates:ROB ads available on a limited basis. Rates for demographic ads are calculated by multiplying the percent of circulation requested (minimum 50%) times the one-time B&W page rate, times the total number of pages, plus applicable color rates at full price, plus a $1,650 (non-commissionable) mechanical charge. Demographic ads will count toward a company’s final earned frequency on a page-for-page basis.

B&W Rates 1x 3x 6x 12x 24x 36x 48x 60x 72x 96x 108x 120x

Tab ,375 6,330 6,200 5,950 5,630 5,515 5,405 5,310 5,210 5,005 4,920 4,830

Island 4,800 4,765 4,655 4,480 4,235 4,160 4,065 4,005 3,935 3,785 3,685 3,655

1/2 page 4,405 4,340 4,265 4,095 3,875 3,825 3,750 3,675 3,605 3,470 3,360 3,315

1/3 page 3,520 3,495 3,420 3,295 3,120 3,065 3,015 2,940 2,900 2,775 2,685 2,625

1/4 page 3,020 2,980 2,925 2,800 2,665 2,610 2,560 2,500 2,450 2,365 2,335 2,290

BRCs 4,105 4,050 3,990 3,830 3,615 3,550 3,495 3,415 3,355 3,240 3,170 3,130

print rates


Urologists ...............................................10,529

Pediatric Urologists .......................................60

Other qualified recipients ............................636

Nurse Practitioner/Physician Assistant .......857

TOTAL QUALIFIED CIRCULATION .... 12,100

Total Qualified Distribution*

*As filed with BPA, subject to audit.Inside





FOCAL THERAPY

John W. Davis, MD

September 2018 VOL. 46, NO. 9 UrologyTimes.com

September 2018 VOL. 46, NO. 9 UrologyTimes.com

with

Readers*




Intracavernosal

injections for ED

Urodynamics

interpretation

Percutaneous tibial

nerve stimulation

Chemotherapy

injections

LHRH antagonist

administration

Urodynamics (place

catheters/perform test)

Cystoscopy for

stent removal

Neuromodulation

with InterStim pro-

gramming

Priapism injection

treatment

55%

40.6%

38.8%

33.8%

29.4%

27.5%

25%

23.8%

23.1%

2014




more APPs in 2017, vs. 62.7% in 2015



BILLED BY APPs


230,683

54,549

2003

56.3%


Which BPH

procedures best

reduce need for

medication?

10 FROM DR. MIAN

5-ARI use reduces

prostate Ca risk for up

to 16 years

11 HANDS ON

Opportunistic

salpingectomy in

female urologic

surgery


Focal therapy for

prostate Ca: Ready

for prime time?

In this interview, John W. Davis, MD,








For U.S. urologists, working with nurse

practitioners and physician assistants

has become more the norm than the

exception.

More than 70% of practicing urologists work

with one or more nurse practitioners and physi-

cian assistants, collectively called advanced prac-

tice providers (APPs), according to 2017 AUA

Census data. By comparison, 62.7% of urologists

worked with an APP in 2015.

“A decade ago it was rare to have advanced

practice providers as part of routine urologic

care. Now they’re integral and a necessary part

of any active urologic practice,” said Bradley A.

Erickson, MD, MS, associate professor of urol-

ogy and surgery, University of Iowa, Iowa City.


Inside

with Readers*


Si 2001Since 2001*Source: Kantar Media


Urologists negotiating employ-ment, payer, or other contracts often feel like they’re navigating unknown, hazardous terrain.

Thomas Stringer, MD, associate professor and associate chairman of urology at Uni-versity of Florida, Gainesville, often reviews residents’ employment contracts. He recalls a recent hospital contract, where he urged the resident to seek clarification in key areas. But the resident wanted the job so much, he felt uncomfortable asking questions and poten-tially turning off the employer.

That’s a mistake, according to Dr. Stringer.“This [contract] is your conditions of

employment. You really need to define what those are so you can feel satisfied once you sign the thing. I think physicians tend to be pretty

anxious about nego-tiating on their own behalf,” he said.

Dr. Stringer, who for 7 years directed the course, “Physician Contract Negotiation: Employment and Owner-ship in the Current Economic Cli-mate,” at AUA annual meetings, says urologists are increasingly called upon to negotiate important and binding documents, like employment contracts.

“More and more physicians, in gener-al, are employed. In the year 2000, almost 60% of all physicians were shareholders in their practices. Currently, that’s clos-er to 30% of all physicians,” Dr. Stringer said. “Our data suggests that the number

PCNL tips and tricks: Access is everything

Win-win contractnegotiations



Q&A

COLLABORATE

Contract negotiations are about col-laborating, not competing. In fact, the process should involve conversation, not negotiation.

KNOW WHO THE PARTIES ARE

Are you contracting on your own behalf or that of the entire practice? This is especially important in managed care contracts.

LOOK FOR WIN-WINS

Explore factors that can be positive for you but also for the practice or other entity you’re negotiating with.

PREPARE

Do your homework. Plenty of information is available online, including from the MGMA (www.mgma.com) and AAMC (www.aamc.org/).

KNOW WHAT YOU WANT

Understand what your top concerns and priorities are, especially since you will likely be unable to negotiate everything you want.

August 2018 VOL. 46, NO. 8 UrologyTimes.com

KEYS TO

SUCCESSFUL

NEGOTIATION

Please see NEGOTIATION, on page 42

STONE SURGERY

Thomas Chi, MD

Practical strategies are available to help you collaborate, not compete

24 MEN’S HEALTH

Alcohol and the prostate gland: Friend or foe?

26 CODING

Medicare proposed rule outlines signifi cant changes

50 MALPRACTICE

Wrong antibiotic leadsto $250K lawsuit

In this interview, Thomas Chi, MD, of the

University of California, San Francisco dis-

cusses how he performs PCNL, explains why

he uses ultrasound instead of fluoroscopy,

and offers advice to urologists looking to

gain more experience with the procedure.

with Readers*



T hree new clinical guidelines, potentially prac-tice-changing advances in robotics and artifi-cial intelligence, and research on public health issues such as opioid abuse were among many high-lights of the AUA annual meeting in San Francisco.

Health policy and practice management in a changing health care landscape, the impact of FDA actions on testosterone replacement and sling sur-gery, the pros and cons of prostate cancer screening and surveillance, and a new focus on care of trans-gender patients were also high-interest topics.

In this article, Urology Times recaps AUA 2018 with our report of the meeting’s annual take-home messages. Messages have been edited for space, and some topics are covered exclusively online. For the full report, visit urologytimes.com/take-homes.

New nmCRPC agent shows rapid PSA decline

SAN FRANCISCO—Treatment with apalutamide (Erleada) resulted in a rapid and substantial decline in PSA, and greater magnitude of PSA decline correlated with improvement in several oncologic endpoints, results from the phase III SPARTAN study showed.

In addition, analyses of PSA data collected in the study confirm that a shorter PSA doubling time (PSADT) is a poor prognostic factor for men with

UROLOGY TIMES STAFF

July 2018 VOL. 46, NO. 7 UrologyTimes.com

Treatment also associated with significant extended median metastasis-free survival

Cheryl Guttman Krader | UT Contributing Editor

Please see nmCRPC AGENT, on page 25

Inside

Best of AUA 2018

New guidance on LUTS/BPH, erectile dysfunc-tion, testosterone defi-ciency; updates to guide on castration-resistant prostate cancer

GUIDELINES

OPIOIDS Surgery-related injuries are down; first study on a new system for RP released

ROBOTICS

AI may improve bladder cancer staging and help determine who needs a prostate MRI

ARTIFICIAL INTELLIGENCEMen’s anxiety lessens over time; phi plus mpMRI better than either alone for predicting grade reclassification

PROSTATE CA SURVEILLANCEUrologists take steps to stem the crisis

Studies in San Fran span wide-ranging clinical, policy topics

Images: Luciano Mortula – LGM, S.Borisov, Ekaterina Pokrovsky, Robert Cicchetti, IM_photo/Shutterstock.com

Please see AUA TAKE-HOMES, on page 17

14 HANDS ONThe argument for surgical management of high-risk PCa

31 CODING Q&ANP, PA incident-to billing: What is (and isn’t) allowed

38 MALPRACTICESpecimen errors carry large consequences

INSERT ADVERTISING RATES – FULL-RUN:

Acceptance: Insert stock weight 80 # text. Contact publisher for approval and pricing for inserts heavier than 80 # text. Submit samples to Production Manager

Demographic Rates: Inserts available on a limited basis. Rates for demographic inserts are calculated by multiplying the percent of circulation requested (minimum 50%) times the one-time B&W page rate, times the total number of pages, plus a

$1,450 (non-commissionable) mechanical charge. Demographic ads will count toward a company’s final earned frequency on a page-for-page basis.

BRCs: BRC must accompany a minimum of a full-page ad. Please contact your sales manager.

Charges: A non-commissionable tip-in charge of $585 will be added for all inserts, including BRCs. Advertisers will be billed at cost for charges incurred due to incorrectly supplied inserts.

Tabloid 1x 3x 6x 12x 24x 36x 48x 60x 72x 96x 108x 120x

2 Page $13,500 $13,405 $13,130 $12,595 $11,920 $11,680 $11,440 $11,245 $11,030 $10,590 $10,420 $10,220

4 Page 26,805 26,260 25,190 23,840 23,360 22,880 22,490 22,055 21,185 20,835 20,440

6 Page 39,390 37,790 35,760 35,040 34,325 33,735 33,080 31,775 31,250 30,660

8 Page 52,520 50,385 47,680 46,720 45,765 44,980 44,105 42,365 41,665 40,880

10 Page 65,645 62,980 59,600 58,400 57,205 56,225 55,135 52,955 52,080 51,100

12 5,575 71,520 70,080 68,645 67,465 66,160 63,545 62,500 61,320

Island 1x 3x 6x 12x 24x 36x 48x 60x 72x 96x 108x 120x

2 Page $9,330 $9,260 $9,040 $8,700 $8,230 $8,080 $7,900 $7,780 $7,640 $7,350 $7,160 $7,100

4 Page 18,520 18,080 17,400 16,460 16,160 15,800 15,560 15,280 14,700 14,320 14,200

6 Page 27,120 26,100 24,690 24,240 23,700 23,340 22,920 22,050 21,480 21,300

8 Page 36,160 34,800 32,920 32,320 31,600 31,120 30,560 29,400 28,640 28,400

10 Page 45,200 43,500 41,150 40,400 39,500 38,900 38,200 36,750 35,800 35,500

12 Page 52,200 49,380 48,480 47,400 46,680 45,840 44,100 42,960 42,600

print rates


discount information

CORPORATE DISCOUNTSEarned Rates: Earned rates are given to advertisers based on advertising frequency within a 12-month period. The earned rate is determined by the number of insertions. A spread counts as two insertions. Full pages and fractional pages count as single insertions. Demographic ads will count toward a company’s final earned frequency on a pro-rated basis (e.g., a 4-page unit going to 50% of circulation = 2X). Insertions from a parent company and its subsidiaries are combined to determine earned rate. Advertisers are short-rated or rebated based on year end final level earned. The minimum number of insertions at each level must be met within the 2019 calendar or fiscal year.

Corporate Discount Program: Effective with January 1, 2019 insertion orders, the Corporate Discount program is based on an advertiser’s 2018 net advertising, including digital spending, plus non-CME promotional project expenditures in all of the UBM Medica media. Please contact your account manager for more information and your discount rate.

2018 Net Corporate Spend Rate Savings 2018 Net

Corporate Spend Rate Savings

$100,000 - $250,000 0.50% $2,500,001 - $3,000,000 5.00%$250,001 - $500,000 0.75% $3,000,001 - $3,500,000 6.00%

$500,001 - $750,000 1.00% $3,500,001 - $4,000,000 8.00%

$750,001 - $1,000,000 1.50% $4,000,001 - $4,500,000 10.00%

$1,000,001 - $1,500,000 2.00% $4,500,001 - $5,000,000 12.00%

$1,500,001 - $2,000,000 3.00% $5,000,001 - $5,500,000 14.00%

$2,000,001 - $2,500,000 4.00% $5,500,001 - $6,000,000 16.00%

Pre-Payment: Prepayment discounts are offered to advertisers; please contact Group Publisher for details.

Multiple Page PI Discount: Ads running more than two pages of prescribing information are offered a discount. Starting with the third PI page of the unit, a 50% discount will be applied to the cost of the page.

ADVERTISING INCENTIVE DISCOUNTSProduct Incentive Program (PIP Continuity Discount): Run a minimum of three product insertions in Urology Times and save. The more insertions, the more you save. Free pages count toward earned frequency but do not count toward the corporate discount program.

Number of Insertions: 3x 6x 9x 12x

Discount: 2% 3% 4% 5%

Product Incentive Program Criteria:

i) The minimum number of insertions at each level must be met within a calendar or fiscal year.

ii) For simplicity, and maximum savings, the Product Incentive Program percent savings will be taken off the product’s gross insertion expenditure. The PIP discount should be added to your corporation’s Corporate Discount Program earned discount, and the resulting total percentage is taken off of the gross insertion cost.

iii) You can project what Product Incentive Program level you will achieve for the year and begin to realize savings immediately. At your earliest convenience, please notify your Urology Times account manager of your product’s planned Product Incentive Program participation level. If the product does not meet the projected level, or exceeds its projected level, that product will be short rated or rebated accordingly. If the product is pulled off the market due to an FDA ruling, the accrued savings will stand, and the company will not be penalized for loss of product continuity.

iv) All of a product’s indications work together to attain a product’s insertion level.

ABC (Add A Book Combo): When you advertise in Urology Times and run the same product in the same month in another UBM Medica medical publication(s) (i.e.,Contemporary OB/GYN, Contemporary Pediatrics, Dermatology Times, Drug Topics, Managed Healthcare Executive, Medical Economics, Oncology, and Psychiatric Times), you will receive a discount dependent upon the number of publications you run in. The more titles you choose, the deeper the discount.

2 publication buy = 10% 3 publication buy = 15% 4+ publication buy = 20%

Note: This discount applies to full run ads only and may not be used when advertising in Ophthalmology Times, Ophthalmology Times Europe, Optometry Times, Dental Products Report and Digital Esthetics. This discount cannot be used in combination with the Product Incentive Plan (PIP) but may be used with the Corporate Discount Program. This discount applies to the nine UBM Medica publications shown only and may be used in any combination. For products with different size ad units, the discount will be calculated based on the mutual number of pages. For example, if 6 pages run in one publication and 4 pages run in the other, under this program, the discount will be applied to the 4 matching pages in each magazine. Free runs do not count toward the discount.


SCREEN REQUIREMENTS Density of Tone: 4C ads not exceed 300%; 2C, 190%; B&W, 95%.1. CMYK is the only accepted mode for 4C ads. Do not use RGB.2. Do not use spot color unless you are paying for a PMS (Pantone) color.3. Colors viewed on your monitor may not be representative of final output.Always check monitor color values against CMYK color swatches and the final KODAK APPROVAL color proof or equivalent. Laser color proofs are for identification only. Should proofs not meet specifications, we will print to published SWOP ink densities. [email protected], [email protected], [email protected], and [email protected].

REPRODUCTION REQUIREMENTS: Follow “Specifications for Web Offset Publication” (SWOP) Tenth Edition for printing in the new millennium. Urology Times is printed Web offset. Our preferred ad page material is an electronic digital file furnished as a PDF/X1a. Any omissions, or color deviation from a submitted proof, other than a quality KODAK APPROVAL or equivalent, will not warrant adjustment for space or color charge.

DISPOSITION OF MATERIAL AND INSERTS: Inserts and electronic ad files are held for one year from date of last insertion and then destroyed. Supplied disks are not returned or retained.

DIGITAL AD REQUIREMENTS:1. Digital data is required for all ad submissions. Preferred format is PDF/X-

1a. Note that a standard PDF is not a preferred format, files should be a PDF/X-1a which is a PDF subset specific to printing. Publisher shall have no obligation or liability to Advertiser of any kind (including, without limitation, the obligation to offer Advertiser makegoods or any other form of compensation) if an ad is supplied to Publisher by Advertiser in any format other than our preferred formats. Non-preferred or non-acceptable formats will be charged a $150 processing fee. All files should be built to exact ad space dimensions purchased. For detailed instructions on preparing PDF/X-1a files and submitting ad files to the correct size, go to https://ads.ubm.com or contact the production manager.

2. Publisher will not supply a faxed or soft proof for Advertiser-supplied files. Advertiser is solely responsible for preflighting and proofing all advertisements prior to submission to Publisher. If Publisher detects an error before going to press, Publisher will make a reasonable effort to contact Advertiser to give Advertiser an opportunity to correct and resubmit Advertiser’s file before publication.

3. Accepted Method of Delivery: The preferred method of delivering ad files to UBM Medica is via a web based ad uploader, https://ads.ubm.com. Files can also be submitted on CD-R or DVD-R disc format.

4. Ad Proofs: To insure that Advertiser’s ad is reproduced correctly, a SWOP-certified color proof that has been made from the same file that Advertiser supplies to Publisher must be provided. Publisher cannot provide Advertiser any assurances regarding the accuracy of reproduction of any ad submitted without a SWOP proof. Publisher shall have no obligation or liability to Advertiser of any kind (including, without limitation, the obligation to offer Advertiser makegoods or any other form of compensation) for any ad supplied to Publisher by Advertiser without a SWOP proof.

PROVIDER INFORMATION REQUIRED: a) Issue date. b) Advertiser, product, and agency name. c) Agency contact person and phone number, or

vendor name and phone number.

d) List of contents (printout of disk contents).

PRINT PRODUCTION MATERIALS: Email Insertion orders, contracts, publication-set copy, reproduction materials, electronic files, proofs and other instructions, to: [email protected]

Send all non-eMailed print materials and other information to:

Urology Times Attn: Karen Lenzen 131 W. 1st Street, Duluth, MN 55802-2065 Phone: 218-740-7271 Email: [email protected]

To submit your ad materials, visit https://ads.ubm.com

print specifications and display ad requirements

COVER TIPSTrimming: Live matter: 7.5” x 6.25”Trim size: 8.25” x 7”Bleed size: 8.5” x 7.25”Thickness: Up to four pages maximum 100# Text to minimum 70# text paper.Cover tips jog to the bottom. Keep live matter 3/4” from edges & gutter trim.

If client supplies, please provide as trim size; 80# stock weight

For anything not matching the specs on cover tips and inserts above, please contact the publisher for special pricing AND send sample for pre-approval to:

UrologyTimesAttn: Karen Lenzen 131 W 1st St, Duluth, MN 55802-2065 Desk: 218-740-7271 Email: [email protected]

INSERTSTrimming: Insert size: Overall size should not exceed 10.5” x 13.75”; Spread insert should Keep live matter 1/2” from trimmed edges & 1/2” from gutter trim Trims: 1⁄8” head, allow 1⁄8” gutter, outside, and foot trim Book is jogged to head

Quantity: Full Run: 15,000

Shipping: a) Delivered on skids with a single band holding a lift together. Skid or pallet CANNOT exceed 42” in height from the floor to the top of the skid or pallet. Failure to meet the requirements may result in a restacking charge passed on to insert supplier.

b) Packing slip MUST have publication name, date, and insert quantity clearly marked. Samples should be attached for identification. Multiple issues or different inserts MUST be packed separated by issue. Publication/printer will not be responsible for inserts destroyed if not separated by issue.

Urology Times c/o LSC Communications Attn: Kyle Bryant 3401 Heartland Drive Liberty, MO 64068 [email protected]


production and editorial calendar 2019

JANUARY ISSUE FEBRUARY ISSUE MARCH ISSUE

APRIL ISSUE MAY ISSUE JUNE ISSUE

» Ad close: December 12 » Materials due: December 18 » Inserts due: December 20

» Ad close: January 14 » Materials due: January 22 » Inserts due: January 24

» Ad close: February 12 » Materials due: February 19 » Inserts due: February 21

» Ad close: March 18 » Materials due: March 22 » Inserts due: March 26

» Ad close: April 12 » Materials due: April 18 » Inserts due: April 22

» Ad close: May 15 » Materials due: May 21 » Inserts due: May 23

Editorial Content*:

Stone Disease Highlights

Editorial Content*:

Prostate Cancer Highlights

Editorial Content*:

Sexual Dysfunction Highlights

Bonus Distribution: American Urological Association’s (AUA) 2019 Annual Meeting, May 3 – 6, Chicago, IL

Editorial Content*:

AUA Annual Meeting Preview

Bonus Distribution: American Urological Association’s (AUA) 2019 Annual Meeting, May 3 – 6, Chicago, IL

Editorial Content*:

AUA Annual Meeting: Early Reports

Editorial Content*:

Men’s Health Highlights

*Editorial features are subject to change


production and editorial calendar 2019

JULY ISSUE AUGUST ISSUE SEPTEMBER ISSUE

OCTOBER ISSUE NOVEMBER ISSUE DECEMBER ISSUE

» Ad close: June 14 » Materials due: June 20 » Inserts due: June 24

» Ad close: July 17 » Materials due: July 23 » Inserts due: July 25

» Ad close: August 14 » Materials due: August 21 » Inserts due: August 23

» Ad close: September 13 » Materials due: September 19 » Inserts due: September 23

» Ad close: October 17 » Materials due: October 23 » Inserts due: October 25

» Ad close: November 13 » Materials due: November 19 » Inserts due: November 21

Editorial Content*:

Technology Highlights

Editorial Content*:

Urologic Cancer Highlights (ASCO Annual Meeting)

Readex Research Ad Performance Study Issue

Editorial Content*:

Prostate Health Month Issue

Editorial Content*:

Female Urology Highlights

Editorial Content*:

Overactive Bladder Highlights

Editorial Content*:

State of the Specialty Exclusive Survey Results

*Editorial features are subject to change



We know healthcare. We get results.We partner with our clients to deliver strategic, integrated communications solutions to key decision-makers through the proven strength of our brands, when and where our clients need it.

contact information

Men’s Healthubmmedica.com/markets-products/mens-health

expert clinical analysis. practice advice. policy

Documents